Propel Bio Management, LLC 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
PB
Propel Bio Management, LLC
Institutional Filer 35.46%$158.7M38

Current Portfolio Holdings

Showing all 38 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1PAGPPlains GP Holdings, L.P.Energy1.3M$30.2M19.02%
2ACHVAchieve Life Sciences, Inc.Healthcare3.8M$11.4M7.17%
3PHATPhathom Pharmaceuticals, Inc.Healthcare841K$9.4M5.90%
4DCTHDelcath Systems, Inc.Healthcare980K$9.2M5.77%
5CORTCorcept Therapeutics IncorporatedHealthcare148K$6.0M3.80%
6ABEOAbeona Therapeutics Inc.Healthcare1.3M$6.0M3.79%
7VORVor Biopharma Inc.Healthcare315K$5.6M3.52%
8KYTXKyverna Therapeutics, Inc.Healthcare644K$5.6M3.52%
9MISTMilestone Pharmaceuticals Inc.Healthcare4.1M$5.1M3.20%
10CLDXCelldex Therapeutics, Inc.Healthcare131K$4.1M2.61%
11CMPSCOMPASS Pathways plcHealthcare742K$4.1M2.60%
12VRDNViridian Therapeutics, Inc.Healthcare210K$4.1M2.58%
13IVAInventiva S.A.Healthcare725K$4.0M2.52%
14SABSSAB Biotherapeutics, Inc.Healthcare1.0M$3.9M2.45%
15OBIOOrchestra BioMed Holdings, Inc.Healthcare897K$3.8M2.41%
Showing 1 to 15 of 38 holdings